Chemokines play an important role in the regulation of endothelial cell (EC) function, including proliferation, migration and differentiation during angiogenesis, and re-endothelialization after injury. In this study, reverse transcriptase-polymerase chain reaction was used to reveal expression of various CXC and CC chemokine receptors in human umbilical vein EC. Northern analysis showed that CXCR4 was selectively expressed in vascular EC, but not in smooth muscle cells. Compared with other chemokines, stromal cell-derived factor-1␣ (SDF-1␣), the known CXCR4 ligand, was an efficacious chemoattractant for EC, causing the migration of ϳ40% input cells with an EC 50 The vascular endothelium is strategically located to play a prominent sensory and effector cell role in the maintenance of hemostasis, and during the vascular response to inflammation, infection, and injury (1, 2). The endothelium is also integrally associated with angiogenesis (3) and cardiovascular disorders such as atherosclerosis and restenosis (4). Endothelial cells (EC) 1 interact with various inflammatory cells, as well as platelets and smooth muscle cells via a variety of chemotactic factors such as chemokines and their receptors (5, 6). Chemokines are classified into at least two groups, which differ with respect to the organization of the dicysteine motif present at the NH 2 terminus. The ␣-chemokines, characterized by the CXC motif include PF-4, IL-8, ␥IP-10 and SDF-1. The -chemokines, characterized by the CC motif include MCP-1, MIP-1␣ and 1, and RANTES (5, 7, 8). Chemokines mediate their specific effect on target cells through two related subfamilies of G-protein coupled receptors. To date, several CXC and CC functional human chemokine receptors have been discovered (9 -16). In line with their well defined role as mediators of diapedesis, the chemokine receptors have been primarily localized on neutrophils, monocytes, lymphocytes, and eosinophils (5). However, little is known about other distinct functions of these cytokines and their interaction with non-hematopoietic cells.Three lines of evidence indicate that human EC also express the genes for chemokine receptors and thus play an active and important role as target cells for chemokine function. First, the proliferation, migration, and differentiation of vascular EC, during angiogenesis, is modulated by chemokines, apparently via specific receptors. Thus, IL-8 is an inducer of angiogenesis (17), whereas PF-4 (18 -20), Gro- (21), and ␥IP-10 (22) are inhibitors of EC proliferation and angiogenesis. Second, it has been suggested that leukocyte adhesion to the endothelium and transmigration require that chemotactic factors be immobilized on the EC surface (23,24). This idea is necessitated due to the obvious conceptual difficulty in generating a chemotactic gradient of soluble chemokines under conditions of blood flow. Although chemokines can bind cell surface proteoglycans (24,25), vascular endothelium may still require expression of receptors that are capable of immobilizing chemokin...